Topotecan Accord 4 mg, Konzentrat zur Herstellung einer Infusionslösung

7680668100026 CH-66810 Konzentrat
Topotecan Accord 4 mg, Konzentrat zur Herstellung einer Infusionslösung
Topotecan Accord 4 mg, Konzentrat zur Herstellung einer Infusionslösung
Topotecan Accord 4 mg, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/01/2024
Summary of Product Characteristics
Français
22/01/2024
Summary of Product Characteristics
Italien
22/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 280.55
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2019

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
66810
Drug name
Topotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01CE01
Authorization status
Z
Dispensing category
A
First authorization
15/03/2019
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Ovarialkarzinom, kleinzelliges Bronchialkarzinom, Zervixkarzinom

Package details

Description (FR)
TOPOTECAN Accord conc perf 4 mg/4ml flac
Description (DE)
TOPOTECAN Accord Inf Konz 4 mg/4ml Durchstf
Market launch
15/03/2019
Narcotic (BTM)
No

Other package sizes (2)

TOPOTECAN Accord conc perf 1 mg/ml flac
1 DUR
GTIN: 7680668100019
View
TOPOTECAN Accord conc perf 4 mg/4ml flac 5 pce
5 DUR
GTIN: 7680668100033
View